This presentation will focus on the impacts of the COVID-19 pandemic on policy, substance use disorder, fatal and non-fatal opioid overdose, treatment, and resilience among American Indian and Alaska Native communities. Facilitators and barriers to access and service delivery of medications for opioid use disorder will also be discussed.
1. Summarize the contributing factors of fatal and non-fatal opioid overdose during the COVID-19 pandemic among American Indian and Alaska Native adults
2. Assess facilitators and barriers to accessing and providing medications for opioid use disorder during COVID-19 among tribal communities
3. Apply lessons learned during the COVID-19 pandemic to improve delivery of medications for opioid use disorder among American Indian and Alaska Native adults
Providence Health Care designates this live activity for a maximum of 1 hour of AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the re-licensure requirements of the Washington State Medical Quality Assurance Commission.
This activity has been planned and implemented in accordance with the accreditation requirements of the Washington State Medical Association through the joint providership of Providence Health Care and Elson S. Floyd College of Medicine. Providence Health Care is accredited by the WSMA to provide continuing medical education for physicians.